aTyr Pharma (ATYR) Earnings Date & Reports

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ATYR is expected to report earnings to rise 5.56% to -18 cents per share on May 07

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.01

The last earnings report on March 13 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 1.27M shares outstanding, the current market capitalization sits at 243.47M.

View a ticker or compare two or three

Compare

ATYR